HRP20030714A2 - Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof - Google Patents

Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof

Info

Publication number
HRP20030714A2
HRP20030714A2 HR20030714A HRP20030714A HRP20030714A2 HR P20030714 A2 HRP20030714 A2 HR P20030714A2 HR 20030714 A HR20030714 A HR 20030714A HR P20030714 A HRP20030714 A HR P20030714A HR P20030714 A2 HRP20030714 A2 HR P20030714A2
Authority
HR
Croatia
Prior art keywords
medicament
derivatives
manufacture
preparation
thiolutin dioxide
Prior art date
Application number
HR20030714A
Other languages
English (en)
Inventor
Eder Claudia
Kurz Michael
Wink Joachim
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of HRP20030714A2 publication Critical patent/HRP20030714A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HR20030714A 2001-03-09 2002-02-23 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof HRP20030714A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01105959A EP1238668A1 (en) 2001-03-09 2001-03-09 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof
PCT/EP2002/001915 WO2002072089A2 (en) 2001-03-09 2002-02-23 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof

Publications (1)

Publication Number Publication Date
HRP20030714A2 true HRP20030714A2 (en) 2005-04-30

Family

ID=8176735

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030714A HRP20030714A2 (en) 2001-03-09 2002-02-23 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof

Country Status (24)

Country Link
US (2) US20020193418A1 (ko)
EP (2) EP1238668A1 (ko)
JP (1) JP2004521927A (ko)
KR (1) KR20040025902A (ko)
CN (1) CN1279906C (ko)
AT (1) ATE333276T1 (ko)
AU (1) AU2002250997B2 (ko)
BG (1) BG108161A (ko)
BR (1) BR0207884A (ko)
CA (1) CA2439853A1 (ko)
CZ (1) CZ20032427A3 (ko)
DE (1) DE60213219D1 (ko)
EE (1) EE200300430A (ko)
HR (1) HRP20030714A2 (ko)
IL (1) IL157792A0 (ko)
MX (1) MXPA03007551A (ko)
NO (1) NO20033964L (ko)
NZ (1) NZ528071A (ko)
PL (1) PL363374A1 (ko)
RU (1) RU2003129889A (ko)
SK (1) SK11202003A3 (ko)
WO (1) WO2002072089A2 (ko)
YU (1) YU68403A (ko)
ZA (1) ZA200306474B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108371661B (zh) * 2018-01-19 2019-03-19 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在抑制nlrp3炎症小体活化中的应用
CN113209088B (zh) * 2021-03-11 2022-03-22 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在保护非酒精性脂肪性肝炎中的应用
CN115261422B (zh) * 2022-06-30 2024-07-16 塔里木大学 一种新物种来源硫藤黄菌素的制备方法及应用
CN118477070B (zh) * 2024-05-15 2025-09-09 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在预防和/或治疗放射性肺损伤中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032396A1 (en) * 1995-04-11 1996-10-17 John Malcolm Webster Xenorxides with antibacterial and antimycotic properties
CA2212237A1 (en) * 1997-09-05 1999-03-05 John M. Webster Novel antineoplastic agents

Also Published As

Publication number Publication date
PL363374A1 (en) 2004-11-15
CN1279906C (zh) 2006-10-18
YU68403A (sh) 2006-08-17
US20020193418A1 (en) 2002-12-19
MXPA03007551A (es) 2003-12-04
SK11202003A3 (sk) 2004-02-03
BG108161A (en) 2004-09-30
ATE333276T1 (de) 2006-08-15
NO20033964D0 (no) 2003-09-08
EP1372640A2 (en) 2004-01-02
CN1501800A (zh) 2004-06-02
JP2004521927A (ja) 2004-07-22
US20050059725A1 (en) 2005-03-17
IL157792A0 (en) 2004-03-28
EP1238668A1 (en) 2002-09-11
CA2439853A1 (en) 2002-09-19
BR0207884A (pt) 2004-07-27
DE60213219D1 (de) 2006-08-31
RU2003129889A (ru) 2005-03-10
CZ20032427A3 (cs) 2004-01-14
EE200300430A (et) 2003-12-15
ZA200306474B (en) 2004-04-29
KR20040025902A (ko) 2004-03-26
AU2002250997B2 (en) 2006-03-09
EP1372640B1 (en) 2006-07-19
NZ528071A (en) 2005-02-25
WO2002072089A2 (en) 2002-09-19
WO2002072089A3 (en) 2002-11-14
NO20033964L (no) 2003-09-08

Similar Documents

Publication Publication Date Title
IL192078A0 (en) Recombinant ??-l-iduronidase,methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
TNSN04082A1 (en) N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
IL152073A0 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
GEP20063920B (en) Alpha-(n-sulphonamido) acetamide derivatives as beta-amyloid inhibitors
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
ATE427114T1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen
IL158738A0 (en) Novel use of 2-phenyl-substituted imidazotriazinones
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
HRP20030714A2 (en) Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof
MXPA03012039A (es) Derivados de benzo [g]quinolina para tratar glaucoma y miopia.
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
EP1736468A3 (en) Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation
MXPA03002047A (es) Fenilciclohexanocarboxamidas substituidas y su uso.
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
BRPI0415529A (pt) derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas
MXPA03008406A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina.
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
WO2003029495A3 (de) Coniosulfide und deren derivate, verfahren zur ihrer herstellung und verwendung als arzneimittel
UA85994C2 (en) N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
AU2358301A (en) Glyoxyl acid amides
MXPA04004537A (es) Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos.
WO2002072527A3 (de) 1-butansäurederivate wie z.b. carbomethoxypropionylcyanid oder leflunomidderivate und deren therapeutische anwendung
UA34171A (uk) Спосіб одержання пігментного двоокису титану з ільменітових концентратів

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

OBST Application withdrawn